These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8774489)
1. Angiogenesis in normal, hyperplastic, and neoplastic endometrium. Morgan KG; Wilkinson N; Buckley CH J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489 [TBL] [Abstract][Full Text] [Related]
2. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
3. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
4. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221 [TBL] [Abstract][Full Text] [Related]
5. Significance of hormone receptor status and tumor vessels in normal, hyperplastic and neoplastic endometrium. Nunobiki O; Taniguchi E; Ishii A; Tang W; Utsunomiya H; Nakamura Y; Mori I; Kakudo K Pathol Int; 2003 Dec; 53(12):846-52. PubMed ID: 14629750 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables. Ozuysal S; Oztürk H; Bilgin T; Filiz G Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230 [TBL] [Abstract][Full Text] [Related]
8. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study. Teni TR; Sampat MB; Sheth NA J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268 [TBL] [Abstract][Full Text] [Related]
9. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
10. Endometrial angiogenesis: from physiology to pathology. Krikun G; Schatz F; Lockwood CJ Ann N Y Acad Sci; 2004 Dec; 1034():27-35. PubMed ID: 15731297 [TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Donoghue JF; Lederman FL; Susil BJ; Rogers PA Hum Reprod; 2007 Jun; 22(6):1705-13. PubMed ID: 17347164 [TBL] [Abstract][Full Text] [Related]
12. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614 [TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin, Bcl-2 and microvessel density in normal, hyperplastic and neoplastic endometrium. Nunobiki O; Nakamura M; Taniguchi E; Utsunomiya H; Mori I; Tsubota Y; Mabuchi Y; Kakudo K Pathol Int; 2009 Aug; 59(8):530-6. PubMed ID: 19627536 [TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression. Kaku T; Kamura T; Hirakawa T; Sakai K; Amada S; Kobayashi H; Nakano H Gynecol Oncol; 1999 Jan; 72(1):51-5. PubMed ID: 9889029 [TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073 [TBL] [Abstract][Full Text] [Related]
16. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463 [TBL] [Abstract][Full Text] [Related]
17. Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium. Paszkowska A; Cybulski M; Semczuk A; Postawski K; Berbe H Cancer Detect Prev; 2000; 24(5):459-63. PubMed ID: 11129988 [TBL] [Abstract][Full Text] [Related]
18. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma. Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468 [TBL] [Abstract][Full Text] [Related]
19. Altered extent, pattern and characteristics of microvascular density are indicators of neoplastic progression in the endometrium. Näyhä V; Viitanen T; Stenbäck F Int J Cancer; 2005 Jul; 115(6):975-80. PubMed ID: 15723304 [TBL] [Abstract][Full Text] [Related]
20. Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding. Al Moghrabi H; Elkeilani A; Thomas JM; Mai KT Pathol Res Pract; 2007; 203(2):79-83. PubMed ID: 17188434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]